vs
Side-by-side financial comparison of NEW JERSEY RESOURCES CORP (NJR) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $939.4M, roughly 1.2× NEW JERSEY RESOURCES CORP). NEW JERSEY RESOURCES CORP runs the higher net margin — 23.3% vs -127.8%, a 151.1% gap on every dollar of revenue. On growth, PERRIGO Co plc posted the faster year-over-year revenue change (-2.5% vs -33.0%). Over the past eight quarters, NEW JERSEY RESOURCES CORP's revenue compounded faster (111.6% CAGR vs 1.3%).
New Jersey Resources is an energy services holding company based in Wall Township, New Jersey. It is a Fortune 1000 company, and a member of the Forbes Platinum 400. New Jersey Natural Gas is its principal subsidiary.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
NJR vs PRGO — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $939.4M | $1.1B |
| Net Profit | $218.9M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | 32.0% | -116.0% |
| Net Margin | 23.3% | -127.8% |
| Revenue YoY | -33.0% | -2.5% |
| Net Profit YoY | 7.2% | -3093.9% |
| EPS (diluted) | $2.16 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $939.4M | — | ||
| Q4 25 | $440.9M | $1.1B | ||
| Q3 25 | $188.3M | $1.0B | ||
| Q2 25 | $234.8M | $1.1B | ||
| Q1 25 | $569.2M | $1.0B | ||
| Q4 24 | $359.0M | $1.1B | ||
| Q3 24 | $265.7M | $1.1B | ||
| Q2 24 | $209.9M | $1.1B |
| Q1 26 | $218.9M | — | ||
| Q4 25 | $122.5M | $-1.4B | ||
| Q3 25 | $15.1M | $7.5M | ||
| Q2 25 | $-15.1M | $-8.4M | ||
| Q1 25 | $204.3M | $-6.4M | ||
| Q4 24 | $131.3M | $-44.4M | ||
| Q3 24 | $91.1M | $-21.0M | ||
| Q2 24 | $-11.6M | $-108.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% |
| Q1 26 | 32.0% | — | ||
| Q4 25 | 40.6% | -116.0% | ||
| Q3 25 | 21.5% | 7.0% | ||
| Q2 25 | -0.5% | 4.3% | ||
| Q1 25 | 49.2% | 4.5% | ||
| Q4 24 | 52.8% | 10.0% | ||
| Q3 24 | 55.0% | 7.4% | ||
| Q2 24 | 2.8% | -2.5% |
| Q1 26 | 23.3% | — | ||
| Q4 25 | 27.8% | -127.8% | ||
| Q3 25 | 8.0% | 0.7% | ||
| Q2 25 | -6.4% | -0.8% | ||
| Q1 25 | 35.9% | -0.6% | ||
| Q4 24 | 36.6% | -3.9% | ||
| Q3 24 | 34.3% | -1.9% | ||
| Q2 24 | -5.5% | -10.2% |
| Q1 26 | $2.16 | — | ||
| Q4 25 | $1.21 | $-10.23 | ||
| Q3 25 | $0.15 | $0.05 | ||
| Q2 25 | $-0.15 | $-0.06 | ||
| Q1 25 | $2.02 | $-0.05 | ||
| Q4 24 | $1.31 | $-0.32 | ||
| Q3 24 | $0.91 | $-0.15 | ||
| Q2 24 | $-0.12 | $-0.79 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $2.9B |
| Total Assets | — | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $2.4M | — | ||
| Q3 25 | $591.0K | $432.1M | ||
| Q2 25 | $931.0K | $454.2M | ||
| Q1 25 | $83.7M | $409.9M | ||
| Q4 24 | $1.9M | $558.8M | ||
| Q3 24 | $1.0M | $1.5B | ||
| Q2 24 | $22.4M | $542.8M |
| Q1 26 | — | — | ||
| Q4 25 | $3.3B | — | ||
| Q3 25 | $3.3B | — | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $3.0B | — | ||
| Q4 24 | $3.0B | — | ||
| Q3 24 | $2.9B | — | ||
| Q2 24 | $2.8B | — |
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | $2.9B | ||
| Q3 25 | $2.4B | $4.4B | ||
| Q2 25 | $2.4B | $4.5B | ||
| Q1 25 | $2.5B | $4.4B | ||
| Q4 24 | $2.3B | $4.3B | ||
| Q3 24 | $2.2B | $4.6B | ||
| Q2 24 | $2.1B | $4.5B |
| Q1 26 | — | — | ||
| Q4 25 | $7.9B | $8.5B | ||
| Q3 25 | $7.6B | $10.1B | ||
| Q2 25 | $7.3B | $10.1B | ||
| Q1 25 | $7.3B | $9.8B | ||
| Q4 24 | $7.2B | $9.6B | ||
| Q3 24 | $7.0B | $11.2B | ||
| Q2 24 | $6.8B | $10.4B |
| Q1 26 | — | — | ||
| Q4 25 | 1.32× | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | 1.20× | — | ||
| Q4 24 | 1.29× | — | ||
| Q3 24 | 1.31× | — | ||
| Q2 24 | 1.30× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $26.7M | $175.4M | ||
| Q3 25 | $81.2M | $51.7M | ||
| Q2 25 | $-28.9M | $75.9M | ||
| Q1 25 | $423.0M | $-64.5M | ||
| Q4 24 | $-9.0M | $312.6M | ||
| Q3 24 | $64.5M | $42.2M | ||
| Q2 24 | $24.3M | $9.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $148.6M | ||
| Q3 25 | — | $29.8M | ||
| Q2 25 | — | $56.7M | ||
| Q1 25 | — | $-90.0M | ||
| Q4 24 | — | $274.9M | ||
| Q3 24 | — | $15.1M | ||
| Q2 24 | — | $-18.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 5.4% | ||
| Q1 25 | — | -8.6% | ||
| Q4 24 | — | 24.2% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | -1.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | 0.22× | — | ||
| Q3 25 | 5.39× | 6.89× | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.07× | — | ||
| Q4 24 | -0.07× | — | ||
| Q3 24 | 0.71× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NJR
| Utility | $640.9M | 68% |
| Nonutility | $298.5M | 32% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
